|
|
|
|
|
by rusk
211 days ago
|
|
> setting up and maintaining production is obnoxiously expensive. This is what I meant by compete on cost. The manufacturers that are best at cutting these costs will make the most profit. That’s where competition should be focused on such generic items. |
|
We've been producing insulin for 100 years now. You guys are just making things up and it's wild.
I don't think a single person who is claiming that regulation is driving up insulin prices has even Googled it to make sure what they're saying makes sense. Spoiler alert: It's not.
The cost of insulin is a result of monopolies, pharmacy benefit managers, patents, and most importantly: a LACK of regulation on drug prices.